• $1.0M
    Market Cap
  • 199,900.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2023
06/30/2022
06/30/2021
Income Statement
Total Operating Revenue
0
-100.00%
18,000
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
18,000
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.5M
-69.63%
-4.8M
-31.39%
-7.0M
N/A
Depreciation and Amortization Expense
373,000
-2.36%
382,000
+1.06%
378,000
N/A
Total Operating Expenses
2.9M
-57.51%
6.9M
-23.27%
9.0M
N/A
Operating Profit
-3.1M
-55.05%
-6.9M
-23.23%
-9.0M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-28,000
-58.82%
-68,000
-56.13%
-155,000
N/A
Interest Income and Expense and Net
-28,000
-58.82%
-68,000
-56.13%
-155,000
N/A
Total Nonoperating Income and Expense
-57,000
-133.14%
172,000
N/A
N/A
N/A
Income before Taxes
-3.2M
-55.01%
-7.0M
-49.24%
-13.9M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.2M
-55.01%
-7.0M
-49.24%
-13.9M
N/A
Net Income from Continuing Operations Applicable to Common
-3.2M
-55.01%
-7.0M
-49.24%
-13.9M
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
-0.04
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
-0.04
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
386.2M
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
386.2M
N/A
Balance Sheet
Cash and Cash Equivalents
1.5M
-60.13%
3.8M
-62.65%
10.2M
N/A
Short-Term Investments
2.7M
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4.2M
+10.64%
3.8M
-62.65%
10.2M
N/A
Total Current Assets
1.6M
-58.65%
4.0M
-63.03%
10.7M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
2.1M
-15.19%
2.4M
-32.16%
3.6M
N/A
Total Assets
7.5M
-27.57%
10.4M
-27.41%
14.3M
N/A
Income Taxes Payable
16,000
+300.00%
4,000
N/A
0
N/A
Total Short-Term Debt
213,000
-14.80%
250,000
-82.82%
1.5M
N/A
Total Current Liabilities
5.0M
+4.43%
4.8M
-26.46%
6.5M
N/A
Total Long-Term Debt
1,080
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
457,000
+730.91%
55,000
-78.17%
252,000
N/A
Total Liabilities
5.5M
-3.03%
5.6M
-16.80%
6.8M
N/A
Retained Earnings
-125.3M
+2.59%
-122.2M
+6.12%
-115.1M
N/A
Total Stockholders Equity
2.0M
-56.89%
4.7M
-37.01%
7.5M
N/A
Total Shares Outstanding
518.3M
+2.87%
503.9M
+16.15%
433.8M
N/A
Cash Flow
Cash from Operating Activities
-2.1M
-66.46%
-6.3M
-33.86%
-9.5M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-60,000
-98.53%
-4.1M
+5,566.67%
-72,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-123,000
-103.10%
4.0M
-71.09%
13.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-38,450.00%
N/A
N/A
N/A
Return on Assets
-35.40%
-37.96%
-57.06%
-51.57%
-117.82%
N/A
Return on Equity
-93.60%
-18.65%
-115.06%
-62.80%
-309.26%
N/A
Revenue Growth
-100.00%
N/A
N/A
N/A
-100.00%
N/A
Current Ratio
0.33
-60.41%
0.82
-49.72%
1.63
N/A
Cash Ratio
0.30
-61.82%
0.79
-49.22%
1.56
N/A
Debt-to-Equity Ratio
0.11
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.03
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow